Drugmaker Cipla has agreed to invest Rs 42 crore in digi-tech company GoApptiv Private Limited, in line with its strategy to invest in “channels of the future”, facilitating access to treatment.

Cipla will hold 22.99 per cent in GoApptiv when the transaction is completed. This is the pharma company’s third investment in GoApptiv, which will be made in a combination of equity shares and compulsorily convertible preference shares, Cipla said. Earlier investments were made in 2022 and 2020.

Incorporated in 2013, GoApptiv provides business solutions to healthcare companies, including distribution, and digital solutions, among other things. It clocked a turnover of ₹864.64 crore for the year ended March 31, 2023.

The transaction is expected to be completed within 60 days of the agreement or on a mutually agreed date, Cipla said. “GoApptiv is an associate of the Company, and hence, the said acquisition would fall within the purview of related party transactions,” Cipla said, adding that the acquisition and subscription of shares will be on an “arm’s length” basis. However, it added that none of the promoters or promoter group companies were interested in the entity.

Umang Vohra, Cipla Managing Director and Chief Executive said the partnership with GoApptiv had helped increase penetration in underserved rural areas of India and address critical healthcare gaps where pharmaceutical coverage is limited. “In this era of technology-driven healthcare, this expanded investment will help us deliver patient-centric solutions and further strengthen our digitisation agenda to drive Cipla’s next phase of growth,” he said.

Related Topics
comment COMMENT NOW